News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Antisoma PLC (ASM.L)'s CEO and Finance Director Leave After Drug Setbacks


3/1/2011 6:42:20 AM

LONDON, Feb 28 (Reuters) - The top management of Antisoma (ASM.L) (ASM.L) stepped down on Monday as the British cancer specialist cut its operations following the failure of its two leading drug candidates. The company's leukaemia drug candidate AS1413 failed in a final-stage trial in January, delivering a second blow after the failure of a lung cancer drug, its biggest hope, in March 2010.

Read at Reuters
Read at News Release

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES